COMMUNIQUÉS West-GlobeNewswire

AAPS Calls for Overruling Jacobson v. Massachusetts, upon Which Vaccine Mandates Are Based
12/06/2024
TUSCON, Ariz., June 12, 2024 (GLOBE NEWSWIRE) -- In its filing with the U.S. Supreme Court on June 10, the Association of Physicians and Surgeons (AAPS) calls for overruling the century-old precedent of Jacobson v. [...]
Positron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CT
12/06/2024
Niagara Falls, NY, June 12, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
12/06/2024
TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of [...]
Cute Season on Parliament Hill – Announcing the Winners of the 2nd Annual Cutest Pets on Parliament Hill Contest
12/06/2024
TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Cute season is in full swing on Parliament Hill and the Canadian Animal Health Institute is thrilled to announce the winners of the 2 nd Annual ‘Cutest Pets on Parliament Hill [...]
C’est la saison des animaux les plus mignons sur la Colline du Parlement - Annonce des gagnants du 2e concours annuel « Les animaux de compagnie les plus mignons sur la Colline du Parlement »
12/06/2024
TORONTO, 12 juin 2024 (GLOBE NEWSWIRE) -- La saison des animaux mignons bat son plein sur la Colline du Parlement et l’Institut canadien de la santé animale est fier d’annoncer les gagnants de son 2e concours annuel « [...]
Verana Health Committed to Revolutionizing Clinical Trials with Enhancements to SaaS Applications
12/06/2024
VeraSite and Verana Trial Connect utilize a comprehensive real-world dataset, coupled with an intuitive user experience, to help sponsors, CROs, and clinicians accelerate clinical trial recruitment and expand clinical [...]
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
12/06/2024
CHATHAM, N.J., June 12, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced it has entered into a [...]
BioSyent In-Licenses Endocrinology Product for Canada
12/06/2024
MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has [...]
Precipio Provides Status Update on Current Business Matters
12/06/2024
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) provides the following update to its shareholders on various business matters looking [...]
Philips launches Duo Venous Stent System for treatment of symptomatic venous outflow obstruction
12/06/2024
June 12, 2024 Sanger Heart & Vascular Institute, Atrium Health, treated the first patient with the new implantable medical device following FDA premarket approval Amsterdam, the Netherlands – Royal Philips (NYSE: [...]
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
12/06/2024
Targeted protein degradation (TPD * ) technologies have demonstrated the potential to produce novel treatment approaches Surrozen’s current SWEETS bispecific antibodies are unique TPD technologies Results demonstrated [...]
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
12/06/2024
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
12/06/2024
Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and the opportunity for Wave’s INHBE program as a best-in-class approach for obesity designed to [...]
Streamline Health® Reports Fiscal First Quarter 2024 Financial Results
11/06/2024
Net loss of ($2.7 million) during the first quarter of fiscal 2024 compared to net loss of ($2.9 million) during the first quarter of fiscal 2023 Adjusted EBITDA improved to a loss of ($0.7 million) during the first [...]
Voting Rights and Shares Capital of the Company
11/06/2024
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, June 11, 2024 (GLOBE NEWSWIRE [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
11/06/2024
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 11 juin 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
11/06/2024
35 new wet-lab tested digital PCR Microbial DNA Detection Assays on research platform GeneGlobe target a wide range of pathogens causing tropical diseases, sexually transmitted and urine tract infections // QIAcuity [...]
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11/06/2024
DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended [...]
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
11/06/2024
SAN FRANCISCO, June 11, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the [...]

Pages